CD274 and neoplasm: This may be explained by some differences in the characteristics of the placebo group with tumor PD-L1 expression level of 1% or more between the overall population and the Japanese population (including ECOG PS 1 or more, pT3, N+, tumor origin at initial diagnosis) (Supplementary Tables S1 and S2).